METHODS: We present a framework of a basic physical exam in a neurologic patient which centers on sensitivity testing, reflex testing and a rectal examination. We will first highlight the key components of sensitivity testing, focusing on the sacral sensitivities and their respective dermatomes. Reflex testing will center on the bulbocavernosus reflex arc in a man and a woman, and the rectal examination will focus on the innervation of the anal sphincter.
INTRODUCTION AND OBJECTIVES: High tone pelvic floor dysfunction (HTPFD) can lead to pelvic pain, elimination dysfunction and dyspareunia. Pelvic floor physical therapy (PFPT) is a mainstay of treatment; however, there are limited additional options when PFPT fails. Thus, we aim to characterize our safe, effective pelvic floor botulinum toxin type A (BoNTA) injection technique.
METHODS: A 31yo female presents with bothersome HTPFD. She attended PFPT without improvement. Options were discussed, and she elects to proceed with injection of BoNTA to the pelvic floor.
RESULTS: The following is an injection of 150u. Setup includes a right angle retractor, maleable retractors, gauze and lidocaine jelly. BoNTA is reconstituted to a concentration of 10u/cc. Sterile prep and surgical towels create a small field.
Fifty units are distributed to the superficial transverse perineii (STP) over 5 injections. The first injection is placed mid-STP. After the needle is withdrawn, gentle massage of the injection site assists with hemostasis and drug distribution.
The medial right and left STP are then injected transcutaneously (10u each). Next, the lateral right and left STP muscle bellies are injected near the ischial tuberosity insertion (10u each).
Attention is then turned to the internal musculature. The maleable retractor is placed vaginally and adjusted to provide exposure. Fifty units are delivered to each levator ani complex over 5 separate 10u injections (proximal to distal) along each muscle belly.
The levator ani complex is isolated between two fingers. The initial insertion of the needle is distal, near the levator complexsymphysis pubis insertion, followed by a quick transition to the left mid levator ani. Gently adjusting the needle depth from medial to lateral helps to distribute the BoNTA from the more medial puborectalis muscle belly to the more lateral iliococcygeus. Last, the more proximal insertion of the levator ani on the coccyx is injected.
Other than the switch from the dominant hand, the right levator ani complex is injected in an identical fashion with palpation to identify musculature followed by injection and massage.
CONCLUSIONS: Pelvic floor muscle BoNTA injections for HTPFD leading to pelvic pain/dyspareunia is a safe, efficacious, minimally-invasive technique, which can be straightforward and have excellent results in properly selected patients. There is a low risk of theoretical complications, such as new-onset SUI or anal incontinence. After two years of inability to tolerate vaginal penetration, our patient was able to have intercourse and orgasms within 1 month post procedure.
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INTRODUCTION AND OBJECTIVES:
Standard open transabdominal repair of VVF requires a long cystotomy, supra-pubic drainage and delayed recovery while laparoscopic repair in limited by difficult suturing in pelvis with steep learning curve. Utility of robotic assistance is being increasingly explored in difficult pelvic surgeries including repair of vesico-vaginal fistula (VVF). In this current video we share our experience and the technical tips of robot-assisted laparoscopic transvesical VVF repair.
METHODS: Data of all patients who underwent robot-assisted VVF repair on DaVinci Si system from December 2014 to September 2018 were collected. All cases underwent pre-operative cysto-vaginoscopy and upper tract imaging. VVF repairs were done in Trendelenburg position with 3-arm pelvic docking. Patient characteristics, operative data, post-operative events and follow up outcomes were analyzed.
RESULTS: Sixty-four cases of VVF were repaired. Posthysterectomy VVF was the commonest etiology. 31 patients had complex VVF. Ureteric catheterization was needed in 13 cases due to close proximity to the fistula site. In 2 patients' simultaneous ureteric reimplantation and in 2 other patients Boari Flap was created (Table 1) . Mean durations of drain and hospital stay were 3.4 AE 1.8 and 9.1 AE 3.8 days respectively. Follow-up of all patients is available and 2 patients had recurrence. In both the patients the fistula was small and at the previous operative site. Both the fistulae were repaired successfully with robotic assistance. Few useful technical tips for successful outcomes are: a) use of different color catheters across the fistula and ureter. b) Intermittent tugging of the catheter (across the fistula) to identify the site for posterior cystotomy, c) Sharp dissection of vaginal and bladder flaps with no or minimal cautrey.
Interposition of local flaps whenever possible. CONCLUSIONS: Current data suggest that robotic-assisted VVF repair is safe and feasible with good success rate conferring the advantages of minimal invasive surgery.
